Patent · US Active

Efficient selectivity of recombinant proteins

US10457959B2 · kind B2 · utility

1Cited by
10References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2017
Grant dateOct 29, 2019
Priority date
Expiry dateJul 31, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides a new expression system comprising a mammalian selectable marker that promotes desirable post-translational modifications of glycoproteins. In particular, the invention includes methods and compositions for optimal recombinant protein expression in mammalian cells by employing a selection marker system based on GPT genes of mammalian origin. The invention includes methods that facilitate selectivity and enhanced expression copies as well as protein yield of recombinant proteins in mammalian cells, and methods of using GPT expression systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.